EnBio Holdings Balance Sheet Health
Financial Health criteria checks 4/6
EnBio Holdings has a total shareholder equity of ¥9.0B and total debt of ¥9.2B, which brings its debt-to-equity ratio to 102.6%. Its total assets and total liabilities are ¥20.2B and ¥11.2B respectively. EnBio Holdings's EBIT is ¥971.0M making its interest coverage ratio 15.7. It has cash and short-term investments of ¥3.0B.
Key information
102.6%
Debt to equity ratio
JP¥9.21b
Debt
| Interest coverage ratio | 15.7x |
| Cash | JP¥3.01b |
| Equity | JP¥8.98b |
| Total liabilities | JP¥11.22b |
| Total assets | JP¥20.20b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 6092's short term assets (¥8.6B) exceed its short term liabilities (¥4.8B).
Long Term Liabilities: 6092's short term assets (¥8.6B) exceed its long term liabilities (¥6.4B).
Debt to Equity History and Analysis
Debt Level: 6092's net debt to equity ratio (69.1%) is considered high.
Reducing Debt: 6092's debt to equity ratio has reduced from 170% to 102.6% over the past 5 years.
Debt Coverage: 6092's debt is not well covered by operating cash flow (18.1%).
Interest Coverage: 6092's interest payments on its debt are well covered by EBIT (15.7x coverage).